Hydralazine tablet labels and packages: Difference between revisions
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AK}} | {{CMG}}; {{AE}} {{AK}} | ||
== | ==Labels and Packages== | ||
PRINCIPAL DISPLAY PANEL | PRINCIPAL DISPLAY PANEL | ||
Revision as of 20:17, 12 March 2014
| Hydralazine |
|---|
| HYDRALAZINE tablet® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings |
| Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| How Supplied/Storage and Handling |
| Labels and Packages |
| HYDRALAZINE injection® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings |
| Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| How Supplied/Storage and Handling |
| Labels and Packages |
| Clinical Trials on Hydralazine |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Labels and Packages
PRINCIPAL DISPLAY PANEL
 |
Hydralazine Hydrochloride Tablets USP 10 mg 100s Label Text
NDC 50111-398-01
HydrALAZINE HYDROCHLORIDE Tablets USP 10 mg
Rx only
100 TABLETS
TEVA
PRINCIPAL DISPLAY PANEL
 |
Hydralazine Hydrochloride Tablets USP 25 mg 100s Label Text
NDC 50111-327-01
HydrALAZINE HYDROCHLORIDE Tablets USP 25 mg
Rx only
100 TABLETS
TEVA
PRINCIPAL DISPLAY PANEL
 |
Hydralazine Hydrochloride Tablets USP 50 mg 100s Label Text
NDC 50111-328-01
HydrALAZINE HYDROCHLORIDE Tablets USP 50 mg
Rx only
100 TABLETS
TEVA
PRINCIPAL DISPLAY PANEL
 |
Hydralazine Hydrochloride Tablets USP 100 mg 100s Label Text
NDC 50111-397-01
HydrALAZINE HYDROCHLORIDE Tablets USP 100 mg
Rx only
100 TABLETS
TEVA[1]
References
- ↑ "HYDRALAZINE HYDROCHLORIDE TABLET [PLIVA INC.]". Retrieved 10 March 2014.